Elevance Health Boston Consulting Group Matrix
Download Your Competitive Advantage
Quick look: Elevance Health’s BCG Matrix teases which business lines are scaling like Stars, which are steady Cash Cows, and which need a rethink. This preview gives you the framing — but the full BCG Matrix delivers quadrant-by-quadrant placement, data-backed recommendations, and strategic moves tied to real market dynamics. Purchase the complete report for a ready-to-present Word analysis plus an Excel summary, and get the clarity you need to allocate capital and act fast.
Stars
Medicare Advantage
Elevance Health's Medicare Advantage franchise is a Star: roughly 6.8 million MA members in 2024 and high enrollment momentum in a market that grew about 7% YoY in 2024 place it in high-share, high-growth territory. It generates strong cash flow but requires ongoing spend on benefits, broker commissions, and medical management. Continued investment is necessary to defend and grow share as competitors scale into MA.
Medicaid managed care (expansion states)
Medicaid managed care in expansion states is a star: states continue to rebid and broaden populations, driving sustained enrollment growth, and contracts often exceed $1 billion with tens–hundreds of millions in capital required. Elevance’s scale and deep care-management capabilities give it leadership in multiple markets, supporting retention and renewal. The upside is real—hold share, win renewals, and double down on quality scores to secure long-term margins.
Carelon Pharmacy (PBM)
Carelon Pharmacy (PBM) sits in the BCG Stars quadrant as rising pharmacy spend fuels integrated PBM growth; IQVIA 2024 shows global medicine spending near 1.6 trillion. Elevance’s PBM holds significant book and strategic weight, making it a market leader with elevated growth. It needs ongoing investment in rebate strategy, specialty and clinical programs to convert into outsized cash as growth normalizes.
Behavioral health integration
Behavioral health integration is a Star for Elevance: US mental health prevalence is about 1 in 5 adults, and Elevance serves roughly 48 million medical members (2023 filings), so integrated behavioral+medical care drives better outcomes and differentiation—supporting growth and share. Scaling requires network build‑out, digital tools, and access expansion; funding this lifts retention and premiums.
- Demand: 1 in 5 adults
- Reach: ~48M members (2023)
- Invest: network, digital, access → retention & premium lift
Value‑based care arrangements
Provider risk‑sharing is scaling rapidly; Elevance reported over $160 billion in 2024 revenue and has expanded value‑based arrangements into double‑digit millions of lives, positioning this as a high‑growth, high‑influence Stars lane.
Elevance’s claims, clinical and social‑determinants data give it leverage to lead; standing up enablement and advanced analytics requires upfront investment but yields strategic margin and network control.
Invest now to lock advantage before market maturation; payoffs include higher medical loss ratio discipline and deeper provider partnerships driving durable share gains.
- Revenue 2024: >160 billion (Elevance)
- Value‑based lives: double‑digit millions
- Strategic ROI: higher margin, better MLR control
MA scale 6.8M, PBM reach $1.6T market
Elevance’s Medicare Advantage (6.8M members in 2024) and Medicaid expansion contracts (> $1B) are Stars, driving high share in a ~7% YoY MA market (2024). Carelon PBM taps $1.6T global medicine spend (IQVIA 2024) but needs investment to monetize. Behavioral integration (~48M medical members, 2023) and value‑based lives (double‑digit millions) require capex to secure margins.
| Metric | 2023/24 Value |
|---|---|
| MA members | 6.8M (2024) |
| Elevance revenue | >$160B (2024) |
| Global med spend | $1.6T (IQVIA 2024) |
| Medical members | ~48M (2023) |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix of Elevance Health, mapping Stars, Cash Cows, Question Marks, Dogs with strategic invest/hold/divest guidance.
Customizable Excel Spreadsheet
One-page Elevance Health BCG Matrix placing each business unit in a quadrant to cut debate and speed C-suite decisions.
Cash Cows
Commercial group (fully insured)
Commercial group (fully insured) sits in a mature employer market with stable share in core geographies and limited organic growth (US employer market growth ~1.5% in 2024). Predictable margins when priced and managed tightly — underwriting discipline, network management and utilization controls drive consistent profitability. Lower incremental promotional spend needed; focus is retention and risk selection. Acts as cash-generating franchise to fund growth while protecting key accounts.
Administrative services only (ASO)
Elevance Healths ASO business sits squarely in Cash Cows: a large, sticky client base buying administration plus network services, supporting roughly 46 million covered lives in 2024 and commanding high share in employer-administered plans while operating in a low-growth market. Fee revenue is steady with limited capital intensity, producing predictable cash flow and allowing efficiency gains to drop to the bottom line. Priority: maintain service quality and upsell care management to sustain margins and extend lifetime value of clients.
PPO network access
Elevance leverages established Blue networks within a Blue Cross Blue Shield system that served over 106 million members in 2024, giving durable demand and high switching costs that preserve membership (Elevance medical membership ~48 million in 2024). Market growth is flat but share remains strong, so minimal promotion beyond account management is needed. Focus on optimized pricing and tightened utilization controls to sustain cash generation.
Care management programs
Care management programs are cash cows: chronic condition and utilization management are mainstream and Elevance runs them at scale with proven ROI; 2024 revenue $173.7B and ~48M members underpin scale. Mature but profitable, incremental investment focuses on automation and targeting to squeeze efficiency while keeping outcomes stable (10–15% fewer hospitalizations; ~$300 annual savings per high‑risk member).
- Scale: 2024 revenue 173.7B; ~48M members
- Impact: 10–15% fewer admissions
- ROI: ≈$300 annual saving per high‑risk member
- Focus: automation, targeted outreach, efficiency
Ancillary: dental, vision, life add‑ons
Ancillary: dental, vision, life add‑ons ride Elevance Health’s core medical sale, capturing high share inside a ~48 million member book (2024); category is slow growth but low capex with dependable incremental margins, bundling sustains retention and lifts ARPU—keep packaging simple, price for margin, avoid over‑engineering.
- High attachment, low capex
- Slow growth, steady margins
- Bundling = retention + ARPU
- Simple packaging, margin pricing
Growth 1.5%, ASO 46M, care saves $300
Commercial fully insured stable in 2024 US employer growth ~1.5%, delivers predictable underwriting margins and funds growth.
ASO supports ~46M covered lives in 2024, low growth, high stickiness, steady fee cash flow and low capex.
Care management scale (2024 revenue 173.7B; ~48M members) cuts admissions 10–15% with ≈$300 annual saving per high‑risk member.
| Metric | 2024 |
|---|---|
| Revenue | 173.7B |
| Members | ~48M |
| ASO covered lives | ~46M |
| BCBS system reach | ~106M |
| Admissions reduction | 10–15% |
| Savings/high‑risk | ~$300 |
Delivered as Shown
Elevance Health BCG Matrix
The file you're previewing here is the exact Elevance Health BCG Matrix you'll receive after purchase — no watermarks, no demo fluff, just the finished, fully formatted report. It's built for strategic clarity and ready to drop into presentations or planning sessions. Once bought, the full document is sent to your inbox and is immediately editable. No surprises, no extra steps — just a clean, professional deliverable.
Download Your Competitive Advantage
Quick look: Elevance Health’s BCG Matrix teases which business lines are scaling like Stars, which are steady Cash Cows, and which need a rethink. This preview gives you the framing — but the full BCG Matrix delivers quadrant-by-quadrant placement, data-backed recommendations, and strategic moves tied to real market dynamics. Purchase the complete report for a ready-to-present Word analysis plus an Excel summary, and get the clarity you need to allocate capital and act fast.
Stars
Medicare Advantage
Elevance Health's Medicare Advantage franchise is a Star: roughly 6.8 million MA members in 2024 and high enrollment momentum in a market that grew about 7% YoY in 2024 place it in high-share, high-growth territory. It generates strong cash flow but requires ongoing spend on benefits, broker commissions, and medical management. Continued investment is necessary to defend and grow share as competitors scale into MA.
Medicaid managed care (expansion states)
Medicaid managed care in expansion states is a star: states continue to rebid and broaden populations, driving sustained enrollment growth, and contracts often exceed $1 billion with tens–hundreds of millions in capital required. Elevance’s scale and deep care-management capabilities give it leadership in multiple markets, supporting retention and renewal. The upside is real—hold share, win renewals, and double down on quality scores to secure long-term margins.
Carelon Pharmacy (PBM)
Carelon Pharmacy (PBM) sits in the BCG Stars quadrant as rising pharmacy spend fuels integrated PBM growth; IQVIA 2024 shows global medicine spending near 1.6 trillion. Elevance’s PBM holds significant book and strategic weight, making it a market leader with elevated growth. It needs ongoing investment in rebate strategy, specialty and clinical programs to convert into outsized cash as growth normalizes.
Behavioral health integration
Behavioral health integration is a Star for Elevance: US mental health prevalence is about 1 in 5 adults, and Elevance serves roughly 48 million medical members (2023 filings), so integrated behavioral+medical care drives better outcomes and differentiation—supporting growth and share. Scaling requires network build‑out, digital tools, and access expansion; funding this lifts retention and premiums.
- Demand: 1 in 5 adults
- Reach: ~48M members (2023)
- Invest: network, digital, access → retention & premium lift
Value‑based care arrangements
Provider risk‑sharing is scaling rapidly; Elevance reported over $160 billion in 2024 revenue and has expanded value‑based arrangements into double‑digit millions of lives, positioning this as a high‑growth, high‑influence Stars lane.
Elevance’s claims, clinical and social‑determinants data give it leverage to lead; standing up enablement and advanced analytics requires upfront investment but yields strategic margin and network control.
Invest now to lock advantage before market maturation; payoffs include higher medical loss ratio discipline and deeper provider partnerships driving durable share gains.
- Revenue 2024: >160 billion (Elevance)
- Value‑based lives: double‑digit millions
- Strategic ROI: higher margin, better MLR control
MA scale 6.8M, PBM reach $1.6T market
Elevance’s Medicare Advantage (6.8M members in 2024) and Medicaid expansion contracts (> $1B) are Stars, driving high share in a ~7% YoY MA market (2024). Carelon PBM taps $1.6T global medicine spend (IQVIA 2024) but needs investment to monetize. Behavioral integration (~48M medical members, 2023) and value‑based lives (double‑digit millions) require capex to secure margins.
| Metric | 2023/24 Value |
|---|---|
| MA members | 6.8M (2024) |
| Elevance revenue | >$160B (2024) |
| Global med spend | $1.6T (IQVIA 2024) |
| Medical members | ~48M (2023) |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix of Elevance Health, mapping Stars, Cash Cows, Question Marks, Dogs with strategic invest/hold/divest guidance.
Customizable Excel Spreadsheet
One-page Elevance Health BCG Matrix placing each business unit in a quadrant to cut debate and speed C-suite decisions.
Cash Cows
Commercial group (fully insured)
Commercial group (fully insured) sits in a mature employer market with stable share in core geographies and limited organic growth (US employer market growth ~1.5% in 2024). Predictable margins when priced and managed tightly — underwriting discipline, network management and utilization controls drive consistent profitability. Lower incremental promotional spend needed; focus is retention and risk selection. Acts as cash-generating franchise to fund growth while protecting key accounts.
Administrative services only (ASO)
Elevance Healths ASO business sits squarely in Cash Cows: a large, sticky client base buying administration plus network services, supporting roughly 46 million covered lives in 2024 and commanding high share in employer-administered plans while operating in a low-growth market. Fee revenue is steady with limited capital intensity, producing predictable cash flow and allowing efficiency gains to drop to the bottom line. Priority: maintain service quality and upsell care management to sustain margins and extend lifetime value of clients.
PPO network access
Elevance leverages established Blue networks within a Blue Cross Blue Shield system that served over 106 million members in 2024, giving durable demand and high switching costs that preserve membership (Elevance medical membership ~48 million in 2024). Market growth is flat but share remains strong, so minimal promotion beyond account management is needed. Focus on optimized pricing and tightened utilization controls to sustain cash generation.
Care management programs
Care management programs are cash cows: chronic condition and utilization management are mainstream and Elevance runs them at scale with proven ROI; 2024 revenue $173.7B and ~48M members underpin scale. Mature but profitable, incremental investment focuses on automation and targeting to squeeze efficiency while keeping outcomes stable (10–15% fewer hospitalizations; ~$300 annual savings per high‑risk member).
- Scale: 2024 revenue 173.7B; ~48M members
- Impact: 10–15% fewer admissions
- ROI: ≈$300 annual saving per high‑risk member
- Focus: automation, targeted outreach, efficiency
Ancillary: dental, vision, life add‑ons
Ancillary: dental, vision, life add‑ons ride Elevance Health’s core medical sale, capturing high share inside a ~48 million member book (2024); category is slow growth but low capex with dependable incremental margins, bundling sustains retention and lifts ARPU—keep packaging simple, price for margin, avoid over‑engineering.
- High attachment, low capex
- Slow growth, steady margins
- Bundling = retention + ARPU
- Simple packaging, margin pricing
Growth 1.5%, ASO 46M, care saves $300
Commercial fully insured stable in 2024 US employer growth ~1.5%, delivers predictable underwriting margins and funds growth.
ASO supports ~46M covered lives in 2024, low growth, high stickiness, steady fee cash flow and low capex.
Care management scale (2024 revenue 173.7B; ~48M members) cuts admissions 10–15% with ≈$300 annual saving per high‑risk member.
| Metric | 2024 |
|---|---|
| Revenue | 173.7B |
| Members | ~48M |
| ASO covered lives | ~46M |
| BCBS system reach | ~106M |
| Admissions reduction | 10–15% |
| Savings/high‑risk | ~$300 |
Delivered as Shown
Elevance Health BCG Matrix
The file you're previewing here is the exact Elevance Health BCG Matrix you'll receive after purchase — no watermarks, no demo fluff, just the finished, fully formatted report. It's built for strategic clarity and ready to drop into presentations or planning sessions. Once bought, the full document is sent to your inbox and is immediately editable. No surprises, no extra steps — just a clean, professional deliverable.
Original: $10.00
-65%$10.00
$3.50Description
Download Your Competitive Advantage
Quick look: Elevance Health’s BCG Matrix teases which business lines are scaling like Stars, which are steady Cash Cows, and which need a rethink. This preview gives you the framing — but the full BCG Matrix delivers quadrant-by-quadrant placement, data-backed recommendations, and strategic moves tied to real market dynamics. Purchase the complete report for a ready-to-present Word analysis plus an Excel summary, and get the clarity you need to allocate capital and act fast.
Stars
Medicare Advantage
Elevance Health's Medicare Advantage franchise is a Star: roughly 6.8 million MA members in 2024 and high enrollment momentum in a market that grew about 7% YoY in 2024 place it in high-share, high-growth territory. It generates strong cash flow but requires ongoing spend on benefits, broker commissions, and medical management. Continued investment is necessary to defend and grow share as competitors scale into MA.
Medicaid managed care (expansion states)
Medicaid managed care in expansion states is a star: states continue to rebid and broaden populations, driving sustained enrollment growth, and contracts often exceed $1 billion with tens–hundreds of millions in capital required. Elevance’s scale and deep care-management capabilities give it leadership in multiple markets, supporting retention and renewal. The upside is real—hold share, win renewals, and double down on quality scores to secure long-term margins.
Carelon Pharmacy (PBM)
Carelon Pharmacy (PBM) sits in the BCG Stars quadrant as rising pharmacy spend fuels integrated PBM growth; IQVIA 2024 shows global medicine spending near 1.6 trillion. Elevance’s PBM holds significant book and strategic weight, making it a market leader with elevated growth. It needs ongoing investment in rebate strategy, specialty and clinical programs to convert into outsized cash as growth normalizes.
Behavioral health integration
Behavioral health integration is a Star for Elevance: US mental health prevalence is about 1 in 5 adults, and Elevance serves roughly 48 million medical members (2023 filings), so integrated behavioral+medical care drives better outcomes and differentiation—supporting growth and share. Scaling requires network build‑out, digital tools, and access expansion; funding this lifts retention and premiums.
- Demand: 1 in 5 adults
- Reach: ~48M members (2023)
- Invest: network, digital, access → retention & premium lift
Value‑based care arrangements
Provider risk‑sharing is scaling rapidly; Elevance reported over $160 billion in 2024 revenue and has expanded value‑based arrangements into double‑digit millions of lives, positioning this as a high‑growth, high‑influence Stars lane.
Elevance’s claims, clinical and social‑determinants data give it leverage to lead; standing up enablement and advanced analytics requires upfront investment but yields strategic margin and network control.
Invest now to lock advantage before market maturation; payoffs include higher medical loss ratio discipline and deeper provider partnerships driving durable share gains.
- Revenue 2024: >160 billion (Elevance)
- Value‑based lives: double‑digit millions
- Strategic ROI: higher margin, better MLR control
MA scale 6.8M, PBM reach $1.6T market
Elevance’s Medicare Advantage (6.8M members in 2024) and Medicaid expansion contracts (> $1B) are Stars, driving high share in a ~7% YoY MA market (2024). Carelon PBM taps $1.6T global medicine spend (IQVIA 2024) but needs investment to monetize. Behavioral integration (~48M medical members, 2023) and value‑based lives (double‑digit millions) require capex to secure margins.
| Metric | 2023/24 Value |
|---|---|
| MA members | 6.8M (2024) |
| Elevance revenue | >$160B (2024) |
| Global med spend | $1.6T (IQVIA 2024) |
| Medical members | ~48M (2023) |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix of Elevance Health, mapping Stars, Cash Cows, Question Marks, Dogs with strategic invest/hold/divest guidance.
Customizable Excel Spreadsheet
One-page Elevance Health BCG Matrix placing each business unit in a quadrant to cut debate and speed C-suite decisions.
Cash Cows
Commercial group (fully insured)
Commercial group (fully insured) sits in a mature employer market with stable share in core geographies and limited organic growth (US employer market growth ~1.5% in 2024). Predictable margins when priced and managed tightly — underwriting discipline, network management and utilization controls drive consistent profitability. Lower incremental promotional spend needed; focus is retention and risk selection. Acts as cash-generating franchise to fund growth while protecting key accounts.
Administrative services only (ASO)
Elevance Healths ASO business sits squarely in Cash Cows: a large, sticky client base buying administration plus network services, supporting roughly 46 million covered lives in 2024 and commanding high share in employer-administered plans while operating in a low-growth market. Fee revenue is steady with limited capital intensity, producing predictable cash flow and allowing efficiency gains to drop to the bottom line. Priority: maintain service quality and upsell care management to sustain margins and extend lifetime value of clients.
PPO network access
Elevance leverages established Blue networks within a Blue Cross Blue Shield system that served over 106 million members in 2024, giving durable demand and high switching costs that preserve membership (Elevance medical membership ~48 million in 2024). Market growth is flat but share remains strong, so minimal promotion beyond account management is needed. Focus on optimized pricing and tightened utilization controls to sustain cash generation.
Care management programs
Care management programs are cash cows: chronic condition and utilization management are mainstream and Elevance runs them at scale with proven ROI; 2024 revenue $173.7B and ~48M members underpin scale. Mature but profitable, incremental investment focuses on automation and targeting to squeeze efficiency while keeping outcomes stable (10–15% fewer hospitalizations; ~$300 annual savings per high‑risk member).
- Scale: 2024 revenue 173.7B; ~48M members
- Impact: 10–15% fewer admissions
- ROI: ≈$300 annual saving per high‑risk member
- Focus: automation, targeted outreach, efficiency
Ancillary: dental, vision, life add‑ons
Ancillary: dental, vision, life add‑ons ride Elevance Health’s core medical sale, capturing high share inside a ~48 million member book (2024); category is slow growth but low capex with dependable incremental margins, bundling sustains retention and lifts ARPU—keep packaging simple, price for margin, avoid over‑engineering.
- High attachment, low capex
- Slow growth, steady margins
- Bundling = retention + ARPU
- Simple packaging, margin pricing
Growth 1.5%, ASO 46M, care saves $300
Commercial fully insured stable in 2024 US employer growth ~1.5%, delivers predictable underwriting margins and funds growth.
ASO supports ~46M covered lives in 2024, low growth, high stickiness, steady fee cash flow and low capex.
Care management scale (2024 revenue 173.7B; ~48M members) cuts admissions 10–15% with ≈$300 annual saving per high‑risk member.
| Metric | 2024 |
|---|---|
| Revenue | 173.7B |
| Members | ~48M |
| ASO covered lives | ~46M |
| BCBS system reach | ~106M |
| Admissions reduction | 10–15% |
| Savings/high‑risk | ~$300 |
Delivered as Shown
Elevance Health BCG Matrix
The file you're previewing here is the exact Elevance Health BCG Matrix you'll receive after purchase — no watermarks, no demo fluff, just the finished, fully formatted report. It's built for strategic clarity and ready to drop into presentations or planning sessions. Once bought, the full document is sent to your inbox and is immediately editable. No surprises, no extra steps — just a clean, professional deliverable.
